Colgate-Palmolive (CL) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Colgate-Palmolive

NYSE•Consumer Defensive•Household & Personal Products

$87.73+0.71(0.01%)After hours

Market Cap

$69.56B

P/E

34.1x

P/S

3.3x

P/B

294.8x

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

How this company scores

GoodMetricSide Score: 61/100

Strongest: Cash & Earnings Quality (23/25); weakest: Balance Sheet & Red Flags (9/25).

Profitability17/25

Growth12/25

Balance Sheet & Red Flags9/25

Cash & Earnings Quality23/25

Strengths

High ROEInterest easily coveredCash-backed earningsConsistent free cash flow

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 34.1x5y range 22.3x – 42.4x

Currently near its 20-quarter median.

P/S · 3.3x5y range 3.1x – 4.2x

Currently near its 20-quarter median.

P/B · 294.8x5y range 75.9x – 1185.0x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

Operating margins dropped 30.7% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.

Leverage Risk

Red Flag

D/E ratio is 33.1 — heavily leveraged and vulnerable to rising rates or cash flow dips.

Price & Volume

Market Cap $69.56B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $21.05B
Q. Revenue: $5.36B
TTM EBITDA: $3.77B
TTM Op. Income: $3.13B
Q. Op. Income: $1.02B
TTM Net Income: $2.04B
Q. Net Income: $693.00M
EPS: $0.87
Shares Out.: $799.40M

$21.05B in TTM revenue grew 5.2% YoY, reaching $5.36B last quarter. TTM EBITDA of $3.77B and TTM operating income of $3.13B show growth is flowing through to the bottom line. TTM net income of $2.04B means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 5 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 61.5%
EBITDA Margin: 21.8%
Op. Margin: 19.0%
Net Margin: 12.9%

Op. margin of 19.0% is down 2.2% YoY — costs are rising relative to revenue. Net margin at 12.9% and gross margin of 61.5% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 34.1x
P/S Ratio: 3.3x
P/B Ratio: 294.8x

At 34.1x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 3.3x and P/B of 294.8x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 3 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $16.79B
Cash: $1.37B
Long-Term Debt: $7.82B
Book Value: $236.00M
D/E Ratio: 33.1
Debt/EBITDA: 6.7

With $16.79B in assets and $7.82B in long-term debt, D/E is 33.1and book value is $236.00M — elevated leverage, meaning significant financial risk in a downturn. Across the last 8 quarters, debt/equity has fallen for 2 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $995.00M
TTM Free Cash Flow: $3.86B
FCF Margin: 18.3%
FCF / Net Income: 1.9

TTM FCF of $3.86B on $995.00M in operating cash flow. The FCF / Net Income ratio of 1.9x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 4 consecutive quarters — an improving trend.